PhaseRx Market Cap

PhaseRx has a market cap or net worth of $12.00 as of December 5, 2025. Its market cap has decreased by -99.97% in one year.

Market Cap

12.00

Enterprise Value

n/a

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since May 18, 2016, PhaseRx's market cap has decreased from 58.15M to 12.00, a decrease of -100.00%. That is a compound annual growth rate of -80.31%.

Market Cap History

Date	Market Cap	% Change
Nov 5, 2025	12.00	-99.49%
Dec 31, 2021	2.34K	-92.59%
Dec 31, 2020	31.61K	285.72%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Veradigm	815.80M
Elite Pharmaceuticals	569.32M
Glass House Brands	503.27M
CytoDyn	416.55M
American Oncology Network	367.13M
Northwest Biotherapeutics	364.92M
Silence Therapeutics	336.78M
Nika Pharmaceuticals	259.91M

Market Cap Rankings